• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[(烷基氨基)甲基]苯乙酮:表皮生长因子受体蛋白酪氨酸激酶的强效和选择性抑制剂。

[(Alkylamino)methyl]acrylophenones: potent and selective inhibitors of the epidermal growth factor receptor protein tyrosine kinase.

作者信息

Traxler P, Trinks U, Buchdunger E, Mett H, Meyer T, Müller M, Regenass U, Rösel J, Lydon N

机构信息

Cancer and Infectious Disease Research Department, CIBA Limited, Basel, Switzerland.

出版信息

J Med Chem. 1995 Jun 23;38(13):2441-8. doi: 10.1021/jm00013a020.

DOI:10.1021/jm00013a020
PMID:7608909
Abstract

[(Alkylamino)methyl]acrylophenones and (alkylamino)propiophenones, bearing a spacer moiety such as the benzyloxy or (benzoylsulfonyl)oxy group in the 4-position, represent a novel class of inhibitors of the epidermal growth factor (EGF) receptor protein tyrosine kinase with a high degree of selectivity versus other tyrosine and serine/threonine kinases. The most active compounds inhibited the EGF receptor protein tyrosine kinase from A431 cell membranes with IC50 values of < 0.5 microM. Derivatives with a benzyloxy substituent in the 4-position of the aromatic ring inhibited both the EGF receptor kinase and the proliferation of an EGF-dependent mouse epidermal keratinocyte cell line (BALB/MK) but were only marginally active in the inhibition of the cellular EGF-dependent tyrosine phosphorylation. Compound 18 inhibited ligand-induced tyrosine phosphorylation and BALB/MK cell proliferation with IC50 values of approximately 100 and 1.21 microM, respectively, and showed antitumor activity in vivo in a nude mouse model. However, the discrepancy between the IC50 values for antiproliferative activity and cellular tyrosine phosphorylation as well as the relatively low tolerability in animals suggests a second site of action of this class of inhibitors. Nevertheless, [(alkylamino)methyl]acrylophenones and (alkylamino)propiophenones may prove to be interesting tools for studying the action of tyrosine kinases.

摘要

在4位带有诸如苄氧基或(苯甲酰磺酰基)氧基等间隔基团的[(烷基氨基)甲基]苯丙烯酮和[(烷基氨基)甲基]苯丙酮,是一类新型的表皮生长因子(EGF)受体蛋白酪氨酸激酶抑制剂,与其他酪氨酸激酶和丝氨酸/苏氨酸激酶相比具有高度选择性。最具活性的化合物对来自A431细胞膜的EGF受体蛋白酪氨酸激酶具有抑制作用,IC50值<0.5 microM。在芳环4位带有苄氧基取代基的衍生物既抑制EGF受体激酶,也抑制EGF依赖性小鼠表皮角质形成细胞系(BALB/MK)的增殖,但在抑制细胞内EGF依赖性酪氨酸磷酸化方面活性仅为边缘水平。化合物18抑制配体诱导的酪氨酸磷酸化和BALB/MK细胞增殖,IC50值分别约为100和1.21 microM,并在裸鼠模型中显示出体内抗肿瘤活性。然而,抗增殖活性和细胞酪氨酸磷酸化的IC50值之间的差异以及在动物中相对较低的耐受性表明这类抑制剂存在第二个作用位点。尽管如此,[(烷基氨基)甲基]苯丙烯酮和[(烷基氨基)甲基]苯丙酮可能被证明是研究酪氨酸激酶作用的有趣工具。

相似文献

1
[(Alkylamino)methyl]acrylophenones: potent and selective inhibitors of the epidermal growth factor receptor protein tyrosine kinase.[(烷基氨基)甲基]苯乙酮:表皮生长因子受体蛋白酪氨酸激酶的强效和选择性抑制剂。
J Med Chem. 1995 Jun 23;38(13):2441-8. doi: 10.1021/jm00013a020.
2
Sulfonylbenzoyl-nitrostyrenes: potential bisubstrate type inhibitors of the EGF-receptor tyrosine protein kinase.磺酰苯甲酰基硝基苯乙烯类:表皮生长因子受体酪氨酸蛋白激酶的潜在双底物型抑制剂。
J Med Chem. 1991 Aug;34(8):2328-37. doi: 10.1021/jm00112a003.
3
Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(phenylamino)pyrazolo[3,4-d]pyrimidines.药效团模型在表皮生长因子受体酪氨酸激酶抑制剂设计中的应用:4-(苯胺基)吡唑并[3,4-d]嘧啶类化合物
J Med Chem. 1997 Oct 24;40(22):3601-16. doi: 10.1021/jm970124v.
4
Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class.2-苯胺基嘧啶类蛋白酪氨酸激酶抑制剂对血小板衍生生长因子信号转导途径的选择性抑制作用
Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2558-62. doi: 10.1073/pnas.92.7.2558.
5
Design and synthesis of novel tyrosine kinase inhibitors using a pharmacophore model of the ATP-binding site of the EGF-R.利用表皮生长因子受体(EGF-R)ATP结合位点的药效团模型设计并合成新型酪氨酸激酶抑制剂。
J Pharm Belg. 1997 Mar-Apr;52(2):88-96.
6
4-(Phenylamino)pyrrolopyrimidines: potent and selective, ATP site directed inhibitors of the EGF-receptor protein tyrosine kinase.4-(苯氨基)吡咯并嘧啶:强效且具选择性的、针对ATP位点的表皮生长因子受体蛋白酪氨酸激酶抑制剂。
J Med Chem. 1996 Jun 7;39(12):2285-92. doi: 10.1021/jm960118j.
7
Clavilactones, a novel class of tyrosine kinase inhibitors of fungal origin.克拉维内酯,一类源自真菌的新型酪氨酸激酶抑制剂。
Biochem Pharmacol. 2000 Jun 15;59(12):1539-47. doi: 10.1016/s0006-2952(00)00278-1.
8
Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors.表皮生长因子受体激酶抑制剂对表皮生长因子依赖的细胞增殖的阻断作用。
Science. 1988 Nov 11;242(4880):933-5. doi: 10.1126/science.3263702.
9
Dianilinophthalimides: potent and selective, ATP-competitive inhibitors of the EGF-receptor protein tyrosine kinase.二苯胺基邻苯二甲酰亚胺:强效且具选择性的ATP竞争性表皮生长因子受体蛋白酪氨酸激酶抑制剂。
J Med Chem. 1994 Apr 1;37(7):1015-27. doi: 10.1021/jm00033a019.
10
AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.AEE788:一种双靶点的表皮生长因子受体/ErbB2及血管内皮生长因子受体酪氨酸激酶抑制剂,具有抗肿瘤和抗血管生成活性。
Cancer Res. 2004 Jul 15;64(14):4931-41. doi: 10.1158/0008-5472.CAN-03-3681.

引用本文的文献

1
Isoflavones, their Glycosides and Glycoconjugates. Synthesis and Biological Activity.异黄酮及其糖苷和糖缀合物。合成与生物活性。
Curr Org Chem. 2017 Jan;21(3):218-235. doi: 10.2174/1385272820666160928120822.
2
Efficient reversal of Alzheimer's disease fibril formation and elimination of neurotoxicity by a small molecule.一种小分子可有效逆转阿尔茨海默病原纤维形成并消除神经毒性。
Proc Natl Acad Sci U S A. 2004 Oct 5;101(40):14326-32. doi: 10.1073/pnas.0405941101. Epub 2004 Sep 23.
3
Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary cultures.
在体外,表皮生长因子受体酪氨酸激酶抑制剂ZD1839对人细胞系和原代培养物中的前列腺癌细胞增殖有显著抑制作用。
J Cancer Res Clin Oncol. 2003 Mar;129(3):165-74. doi: 10.1007/s00432-003-0420-3. Epub 2003 Mar 4.
4
In vivo pharmacology and anti-tumour evaluation of the tyrphostin tyrosine kinase inhibitor RG13022.酪氨酸激酶抑制剂RG13022的体内药理学及抗肿瘤评估
Br J Cancer. 1996 Dec;74(11):1714-8. doi: 10.1038/bjc.1996.620.